Silence Therapeutics (SLN) Stock Price, News, Quotes-Moomoo

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Silence Therapeutics Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags
Yahoo FinanceMar 1 08:25 ET
Silence Therapeutics Plc (SLN) Q4 2024 Earnings Call Transcript Summary
moomoo AIFeb 28 12:01 ET · Conference Call
European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Remain Flat for Week
MT NewswiresFeb 28 11:03 ET
Strategic Focus and Market Opportunities Drive Buy Rating for Silence Therapeutics
TipRanksFeb 28 07:46 ET · Ratings
Jefferies Maintains Silence Therapeutics(SLN.US) With Buy Rating, Cuts Target Price to $30
Moomoo NewsFeb 28 02:31 ET · Ratings
Analysts Offer Insights on Healthcare Companies: Keros Therapeutics (KROS), Kura Oncology (KURA) and Silence Therapeutics (SLN)
TipRanksFeb 28 01:40 ET · Ratings

Comments

Trytosaveabit

Feb 27 07:31

Not too shabby

$Silence Therapeutics (SLN.US)$ Silence Therapeutics (NASDAQ:SLN) reported quarterly losses of $(0.33) per share. This is a 32.65 percent increase over losses of $(0.49) per share from the same period last year. The company reported $43.26 million in sales this quarter. This is a 36.71 percent increase over sales of $31.64 million the same period last year.

2

PYUN970IHaveChosen

Jan 2 09:17

👀👀👀

$Silence Therapeutics (SLN.US)$

PYUN970IHaveChosen

Dec 20, 2024 13:40

👀👀👀……..

$Silence Therapeutics (SLN.US)$

Jaguar8

Dec 9, 2024 06:56

NEWS

$Silence Therapeutics (SLN.US)$
Silence Therapeutics Presents Promising Phase 1 Data in Polycythemia Vera Patients at the American Society of Hematology (ASH) Annual Meeting
Silence Therapeutics presented additional Phase 1 results for divesiran in polycythemia vera (PV) patients at the ASH Annual Meeting. The SANRECO study data showed substantial reduction in phlebotomy frequency and lower hematocrit levels in 19 PV patients. Following treatment, only five phlebotomies were required during t...

Mcsnacks H Tupack

Nov 22, 2024 02:52

Top 2 Long Term stocks(3 months)

$Silence Therapeutics (SLN.US)$ Stock rated a buy and with the lowest PT being $31. Had the same dip last year so it will be around February 21 when it reaches its PT.
$Rezolve AI (RZLV.US)$ Alot of short shares sold this month and in September. Reversal should be starting now that it has reached $1.63. First climb will be to 4.70 with that PT being at the end of December. February's PT will be 12.00. Partnerships with Microsoft and Google will push it until they re...

7

SLN Silence Therapeutics

Trade Overview

Capital Trend

News

Comments

Trending Stocks